Plasma homocysteine and parental myocardial infarction in young adults in Jerusalem

J D Kark1, R Sinnreich, I H Rosenberg

  • 1Epidemiology Unit, Hadassah University Hospital, Jerusalem, Israel. jeremykark@hujc.ac.il

Circulation
|June 12, 2002
PubMed

Insights

Elevated plasma homocysteine (tHcy) in young men appears to precede cardiovascular disease, suggesting a causal link. This finding may explain higher coronary heart disease rates in Israel.

Area of Science:

  • Cardiovascular Science
  • Metabolic Health
  • Genetics and Epidemiology

Background:

  • The causal role of elevated plasma homocysteine (tHcy) in cardiovascular disease (CVD) remains unclear.
  • Investigating the temporal relationship between tHcy and CVD is crucial for understanding disease etiology.
  • Previous studies have yielded conflicting results regarding tHcy's association with CVD.

Purpose of the Study:

  • To determine the familial association between tHcy and parental myocardial infarction (MI) in young adults.
  • To compare tHcy levels in Jerusalem, a high coronary heart disease (CHD) area, with US population data.
  • To clarify the antecedent-consequent directionality of the tHcy-CVD relationship.

Main Methods:

  • A cohort study involving 8646 17-year-olds and 6952 parents in Jerusalem.
  • Follow-up reexamination of offspring at ages 28-32, comparing those with and without parental MI.
  • Comparison of tHcy levels between Jerusalem and US (NHANES III) populations, adjusting for vitamin B12 levels.

Main Results:

  • Young male offspring of parents with MI had significantly higher tHcy levels than controls.
  • A graded increase in the risk of parental MI was observed across increasing quintiles of offspring tHcy.
  • Jerusalem men exhibited higher tHcy than US men, partly due to lower vitamin B12 levels.

Conclusions:

  • Elevated tHcy in young male offspring suggests it precedes the manifestation of CHD.
  • Higher population tHcy levels in Israeli men may contribute to the high incidence of CHD in Israel.
  • These findings support a potential causal role for tHcy in the development of cardiovascular disease.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
769
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
891
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
500
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
891